131 related articles for article (PubMed ID: 8895247)
1. Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils.
Rupniak NMJ; Carlson E; Boyce S; Webb JK; Hill RG
Pain; 1996 Sep; 67(1):189-195. PubMed ID: 8895247
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive activity of the tachykinin NK1 receptor antagonist, CP-99,994, in conscious gerbils.
Rupniak NM; Webb JK; Williams AR; Carlson E; Boyce S; Hill RG
Br J Pharmacol; 1995 Sep; 116(2):1937-43. PubMed ID: 8528583
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of foot tapping and chromodacryorrhoea in gerbils by CNS penetrant and non-penetrant tachykinin NK1 receptor antagonists.
Rupniak NM; Williams AR
Eur J Pharmacol; 1994 Nov; 265(3):179-83. PubMed ID: 7533096
[TBL] [Abstract][Full Text] [Related]
4. Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils.
Bristow LJ; Young L
Eur J Pharmacol; 1994 Mar; 253(3):245-52. PubMed ID: 7515350
[TBL] [Abstract][Full Text] [Related]
5. Maturation of NK1 receptor involvement in the nociceptive response to formalin.
King TE; Cheng J; Wang S; Barr GA
Synapse; 2000 Jun; 36(4):254-66. PubMed ID: 10819903
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists.
Rupniak NM; Tattersall FD; Williams AR; Rycroft W; Carlson EJ; Cascieri MA; Sadowski S; Ber E; Hale JJ; Mills SG; MacCoss M; Seward E; Huscroft I; Owen S; Swain CJ; Hill RG; Hargreaves RJ
Eur J Pharmacol; 1997 May; 326(2-3):201-9. PubMed ID: 9196273
[TBL] [Abstract][Full Text] [Related]
7. The neurokinin-1 receptor antagonist, sendide, exhibits antinociceptive activity in the formalin test.
Sakurada T; Katsumata K; Yogo H; Tan-No K; Sakurada S; Ohba M; Kisara K
Pain; 1995 Feb; 60(2):175-180. PubMed ID: 7540280
[TBL] [Abstract][Full Text] [Related]
8. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of T-2328, 2-fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptor.
Watanabe Y; Asai H; Ishii T; Kiuchi S; Okamoto M; Taniguchi H; Nagasaki M; Saito A
J Pharmacol Sci; 2008 Jan; 106(1):121-7. PubMed ID: 18187929
[TBL] [Abstract][Full Text] [Related]
10. LY303870, a centrally active neurokinin-1 antagonist with a long duration of action.
Iyengar S; Hipskind PA; Gehlert DR; Schober D; Lobb KL; Nixon JA; Helton DR; Kallman MJ; Boucher S; Couture R; Li DL; Simmons RM
J Pharmacol Exp Ther; 1997 Feb; 280(2):774-85. PubMed ID: 9023291
[TBL] [Abstract][Full Text] [Related]
11. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
Beattie DT; Beresford IJ; Connor HE; Marshall FH; Hawcock AB; Hagan RM; Bowers J; Birch PJ; Ward P
Br J Pharmacol; 1995 Dec; 116(8):3149-57. PubMed ID: 8719789
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist.
Ballard TM; Sänger S; Higgins GA
Eur J Pharmacol; 2001 Feb; 412(3):255-64. PubMed ID: 11166289
[TBL] [Abstract][Full Text] [Related]
13. Non-specific inhibition of dopamine receptor agonist-induced behaviour by the tachykinin NK1 receptor antagonist CP-99,994 in guinea-pigs.
Rupniak NM; Jackson A
Eur J Pharmacol; 1994 Sep; 262(1-2):171-5. PubMed ID: 7529183
[TBL] [Abstract][Full Text] [Related]
14. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
[TBL] [Abstract][Full Text] [Related]
15. Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists.
Duffy RA; Varty GB; Morgan CA; Lachowicz JE
J Pharmacol Exp Ther; 2002 May; 301(2):536-42. PubMed ID: 11961054
[TBL] [Abstract][Full Text] [Related]
16. Non-specific effects of the tachykinin NK1 receptor antagonist, CP-99,994, in antinociceptive tests in rat, mouse and gerbil.
Smith G; Harrison S; Bowers J; Wiseman J; Birch P
Eur J Pharmacol; 1994 Dec; 271(2-3):481-7. PubMed ID: 7705448
[TBL] [Abstract][Full Text] [Related]
17. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580.
Rupniak NM; Boyce S; Williams AR; Cook G; Longmore J; Seabrook GR; Caeser M; Iversen SD; Hill RG
Br J Pharmacol; 1993 Dec; 110(4):1607-13. PubMed ID: 8306108
[TBL] [Abstract][Full Text] [Related]
19. Differential roles of spinal neurokinin 1/2 receptors in development of persistent spontaneous nociception and hyperalgesia induced by subcutaneous bee venom injection in the conscious rat.
Zheng JH; Chen J
Neuropeptides; 2001 Feb; 35(1):32-44. PubMed ID: 11346308
[TBL] [Abstract][Full Text] [Related]
20. Differential antinociceptive effects of sendide, a NK1-receptor antagonist, and morphine in the capsaicin test.
Sakurada T; Yogo H; Katsumata K; Tan-No K; Sakurada S; Kisara K; Ohba M
Brain Res; 1994 Jun; 649(1-2):319-22. PubMed ID: 7525010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
